革命性的抗凝:纳米工程疗法和精准医学方法

IF 5.3 2区 医学 Q1 PHARMACOLOGY & PHARMACY
Ying Zhang , Wenqiang Qian , Weidong Fei , Yongquan Zheng , Yao Yao , Maiqi Kong , Xiaojun Zhu , Yujie Peng , Dan He , Caihong Zheng
{"title":"革命性的抗凝:纳米工程疗法和精准医学方法","authors":"Ying Zhang ,&nbsp;Wenqiang Qian ,&nbsp;Weidong Fei ,&nbsp;Yongquan Zheng ,&nbsp;Yao Yao ,&nbsp;Maiqi Kong ,&nbsp;Xiaojun Zhu ,&nbsp;Yujie Peng ,&nbsp;Dan He ,&nbsp;Caihong Zheng","doi":"10.1016/j.ijpharm.2025.125596","DOIUrl":null,"url":null,"abstract":"<div><div>With the advancement of therapeutic concepts, early intervention with antithrombotic therapy for patients at potential thrombotic risk is becoming more proactive. Anticoagulant therapy, a critical component of antithrombotic treatment, thus plays a key role in the prevention and treatment of cardiovascular diseases. Unfortunately, existing anticoagulation treatments still face many challenges, including abnormal bleeding, allergic reactions, and drug resistance. To identify novel technologies for addressing these issues and explore the latest research developments in the field of anticoagulation, this paper reviewed the advances of anticoagulant factor-loaded nanoplatforms firstly. These systems can precisely deliver anticoagulant drugs to specific targets, improving drug bioavailability and reducing unnecessary systemic side effects. Subsequently, the paper delved into the development of anticoagulant technologies, including the advancements in biocompatible anticoagulant nanomaterials, the application of DNA origami technology, and the progress in external energy-mediated anticoagulation strategies. A common feature of these engineered anticoagulation systems is their ability to modulate the dynamic balance of anticoagulant factors in the body without relying on traditional drugs, enabling more personalized and efficient anticoagulation effects. Finally, the paper examined novel precision anticoagulation strategies that combine biomedical engineering technologies with precision anticoagulation therapy. These strategies can tailor anticoagulation treatments to the specific pathological conditions of individual patients, such as thrombin activity, thereby reducing the risk of excessive anticoagulation. In conclusion, the engineered anticoagulation therapy strategies proposed in this paper represent cutting-edge advancements in anticoagulation medicine, providing more precise and safer solutions for the treatment of thrombotic diseases, and offering important theoretical and practical guidance for future personalized medicine and precision therapies.</div></div>","PeriodicalId":14187,"journal":{"name":"International Journal of Pharmaceutics","volume":"676 ","pages":"Article 125596"},"PeriodicalIF":5.3000,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Revolutionizing anticoagulation: Nanoengineered therapies and precision medicine approaches\",\"authors\":\"Ying Zhang ,&nbsp;Wenqiang Qian ,&nbsp;Weidong Fei ,&nbsp;Yongquan Zheng ,&nbsp;Yao Yao ,&nbsp;Maiqi Kong ,&nbsp;Xiaojun Zhu ,&nbsp;Yujie Peng ,&nbsp;Dan He ,&nbsp;Caihong Zheng\",\"doi\":\"10.1016/j.ijpharm.2025.125596\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>With the advancement of therapeutic concepts, early intervention with antithrombotic therapy for patients at potential thrombotic risk is becoming more proactive. Anticoagulant therapy, a critical component of antithrombotic treatment, thus plays a key role in the prevention and treatment of cardiovascular diseases. Unfortunately, existing anticoagulation treatments still face many challenges, including abnormal bleeding, allergic reactions, and drug resistance. To identify novel technologies for addressing these issues and explore the latest research developments in the field of anticoagulation, this paper reviewed the advances of anticoagulant factor-loaded nanoplatforms firstly. These systems can precisely deliver anticoagulant drugs to specific targets, improving drug bioavailability and reducing unnecessary systemic side effects. Subsequently, the paper delved into the development of anticoagulant technologies, including the advancements in biocompatible anticoagulant nanomaterials, the application of DNA origami technology, and the progress in external energy-mediated anticoagulation strategies. A common feature of these engineered anticoagulation systems is their ability to modulate the dynamic balance of anticoagulant factors in the body without relying on traditional drugs, enabling more personalized and efficient anticoagulation effects. Finally, the paper examined novel precision anticoagulation strategies that combine biomedical engineering technologies with precision anticoagulation therapy. These strategies can tailor anticoagulation treatments to the specific pathological conditions of individual patients, such as thrombin activity, thereby reducing the risk of excessive anticoagulation. In conclusion, the engineered anticoagulation therapy strategies proposed in this paper represent cutting-edge advancements in anticoagulation medicine, providing more precise and safer solutions for the treatment of thrombotic diseases, and offering important theoretical and practical guidance for future personalized medicine and precision therapies.</div></div>\",\"PeriodicalId\":14187,\"journal\":{\"name\":\"International Journal of Pharmaceutics\",\"volume\":\"676 \",\"pages\":\"Article 125596\"},\"PeriodicalIF\":5.3000,\"publicationDate\":\"2025-04-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Pharmaceutics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0378517325004338\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PHARMACOLOGY & PHARMACY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Pharmaceutics","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0378517325004338","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

摘要

随着治疗理念的进步,对有血栓形成潜在危险的患者进行抗栓治疗的早期干预变得更加积极主动。抗凝治疗是抗血栓治疗的重要组成部分,在心血管疾病的预防和治疗中起着关键作用。不幸的是,现有的抗凝治疗仍然面临许多挑战,包括异常出血、过敏反应和耐药性。为了寻找解决这些问题的新技术,并探索抗凝领域的最新研究进展,本文首先综述了抗凝因子负载纳米平台的研究进展。这些系统可以精确地将抗凝药物输送到特定的靶点,提高药物的生物利用度,减少不必要的全身副作用。随后,本文深入探讨了抗凝技术的发展,包括生物相容性抗凝纳米材料的进展,DNA折纸技术的应用,以及外部能量介导抗凝策略的进展。这些工程抗凝系统的一个共同特点是它们能够在不依赖于传统药物的情况下调节体内抗凝因子的动态平衡,从而实现更个性化和有效的抗凝效果。最后,本文探讨了将生物医学工程技术与精密抗凝治疗相结合的新型精密抗凝策略。这些策略可以根据个体患者的特定病理状况(如凝血酶活性)量身定制抗凝治疗,从而降低过度抗凝的风险。总之,本文提出的工程化抗凝治疗策略代表了抗凝医学的前沿进展,为血栓性疾病的治疗提供了更精确、更安全的解决方案,为未来的个性化医疗和精准治疗提供了重要的理论和实践指导。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Revolutionizing anticoagulation: Nanoengineered therapies and precision medicine approaches

Revolutionizing anticoagulation: Nanoengineered therapies and precision medicine approaches
With the advancement of therapeutic concepts, early intervention with antithrombotic therapy for patients at potential thrombotic risk is becoming more proactive. Anticoagulant therapy, a critical component of antithrombotic treatment, thus plays a key role in the prevention and treatment of cardiovascular diseases. Unfortunately, existing anticoagulation treatments still face many challenges, including abnormal bleeding, allergic reactions, and drug resistance. To identify novel technologies for addressing these issues and explore the latest research developments in the field of anticoagulation, this paper reviewed the advances of anticoagulant factor-loaded nanoplatforms firstly. These systems can precisely deliver anticoagulant drugs to specific targets, improving drug bioavailability and reducing unnecessary systemic side effects. Subsequently, the paper delved into the development of anticoagulant technologies, including the advancements in biocompatible anticoagulant nanomaterials, the application of DNA origami technology, and the progress in external energy-mediated anticoagulation strategies. A common feature of these engineered anticoagulation systems is their ability to modulate the dynamic balance of anticoagulant factors in the body without relying on traditional drugs, enabling more personalized and efficient anticoagulation effects. Finally, the paper examined novel precision anticoagulation strategies that combine biomedical engineering technologies with precision anticoagulation therapy. These strategies can tailor anticoagulation treatments to the specific pathological conditions of individual patients, such as thrombin activity, thereby reducing the risk of excessive anticoagulation. In conclusion, the engineered anticoagulation therapy strategies proposed in this paper represent cutting-edge advancements in anticoagulation medicine, providing more precise and safer solutions for the treatment of thrombotic diseases, and offering important theoretical and practical guidance for future personalized medicine and precision therapies.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
10.70
自引率
8.60%
发文量
951
审稿时长
72 days
期刊介绍: The International Journal of Pharmaceutics is the third most cited journal in the "Pharmacy & Pharmacology" category out of 366 journals, being the true home for pharmaceutical scientists concerned with the physical, chemical and biological properties of devices and delivery systems for drugs, vaccines and biologicals, including their design, manufacture and evaluation. This includes evaluation of the properties of drugs, excipients such as surfactants and polymers and novel materials. The journal has special sections on pharmaceutical nanotechnology and personalized medicines, and publishes research papers, reviews, commentaries and letters to the editor as well as special issues.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信